eIF2α phosphorylation bypasses premature senescence caused by oxidative stress and pro-oxidant antitumor therapies

Aging (Impact Factor: 6.43). 12/2013; 5(12).
Source: PubMed


Eukaryotic cells respond to various forms of stress by blocking mRNA translation initiation via the phosphorylation of the alpha (α) subunit of eIF2 at serine 51 (S51) (eIFαP). An important role of eIF2αP is the regulation of redox homeostasis and adaptation of cells to oxidative stress. Herein, we demonstrate that eIF2αP guards cells from intracellular reactive oxygen species (ROS) via the inhibition of senescence. Specifically, genetic inactivation of either eIF2αP or eIF2α kinase PERK in primary mouse or human fibroblasts leads to proliferative defects associated with increased DNA damage, G2/M accumulation and induction of premature senescence. Impaired proliferation of either PERK or eIF2αP-deficient primary cells is caused by increased ROS and restored by anti-oxidant treatment. Contrary to primary cells, impaired eIF2αP in immortalized mouse fibroblasts or human tumor cells provides tolerance to elevated intracellular ROS levels. However, eIF2αP-deficient human tumor cells are highly susceptible to extrinsic ROS generated by the pro-oxidant drug doxorubicin by undergoing premature senescence. Our work demonstrates that eIF2αP determines cell destiny through its capacity to control senescence in response to oxidative stress. Also, inhibition of eIF2αP may be a suitable means to increase the anti-tumor effects of pro-oxidant drugs through the induction of senescence.

Download full-text


Available from: Randal J Kaufman, Jul 15, 2014
36 Reads
  • Source
    • "vectors and selected in 200 μg/ml of zeocin (Invitrogen) as described.20 The generation of HT1080 KI cells was described elsewhere.31 "
    [Show abstract] [Hide abstract]
    ABSTRACT: The endoplasmic reticulum (ER)-resident protein kinase PERK is a major component of the unfolded protein response (UPR), which promotes the adaptation of cells to various forms of stress. PERK phosphorylates the α subunit of the translation initiation factor eIF2 at serine 51, a modification that plays a key role in the regulation of mRNA translation in stressed cells. Several studies have demonstrated that the PERK-eIF2α phosphorylation pathway maintains insulin biosynthesis and glucose homeostasis, facilitates tumor formation and decreases the efficacy of tumor treatment with chemotherapeutic drugs. Recently, a selective catalytic PERK inhibitor termed GSK2656157 has been developed with anti-tumor properties in mice. Herein, we provide evidence that inhibition of PERK activity by GSK2656157 does not always correlate with inhibition of eIF2α phosphorylation. Also, GSK2656157 does not always mimic the biological effects of the genetic inactivation of PERK. Furthermore, cells treated with GSK2656157 increase eIF2α phosphorylation as a means to compensate for the loss of PERK. Using human tumor cells impaired in eIF2α phosphorylation, we demonstrate that GSK2656157 increases ER stress-mediated death suggesting that the drug acts independent of inhibition of eIF2α phosphorylation. We conclude that GSK2656157 might be a useful compound to dissect pathways that compensate for the loss of PERK and/or identify PERK pathways that are independent of eIF2α phosphorylation.
    Cell cycle (Georgetown, Tex.) 01/2014; 13(5). DOI:10.4161/cc.27726 · 4.57 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ageing is manifested as functional and structural deterioration that affects cell and tissue physiology. mRNA translation is a central cellular process, supplying cells with newly synthesized proteins. Accumulating evidence suggests that alterations in protein synthesis are not merely a corollary but rather a critical factor for the progression of ageing. Here we survey protein synthesis regulatory mechanisms and focus on the pre-translational regulation of the process exerted by non-coding RNA species, RNA binding proteins and alterations of intrinsic RNA properties. In addition, we discuss the tight relationship between mRNA translation and two central pathways that modulate ageing, namely the Insulin/IGF-1 and TOR signalling cascades. A thorough understanding of the complex interplay between protein synthesis regulation and ageing will provide critical insights into the pathogenesis of age-related disorders, associated with impaired proteostasis and protein quality control. Copyright © 2014. Published by Elsevier B.V.
    Ageing Research Reviews 12/2014; 23(Pt A). DOI:10.1016/j.arr.2014.12.008 · 4.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The 1st World Congress on Geriatrics and Neurodegenerative Disease Research (GeNeDis 2014), focused on recent advances in geriatrics and neurodegeneration, ranging from basic science to clinical and pharmaceutical developments, providing an international forum for the latest scientific discoveries, medical practices and care initiatives. Advances information technologies had been discussed along with their implications for various research, implementation and policy concerns. In addition, the conference addressed several European and global issues in the funding of long-term care and medico-social policies regarding elderly people. GeNeDis 2014 took place in Corfu, Greece, 10-13 April 2014. This volume focuses on the sessions that address Computational Biology and Bioinformatics.
    1 edited by Athanasios T. Alexiou, Panayiotis Vlamos, 01/2015; Springer International Publishing., ISBN: 978-3-319-08926-3
Show more